Top Dividend Stocks to Navigate Market Uncertainty in August

3 min read | August 08, 2024 03:10 AM AEST | By Team Kalkine Media

Headlines

  1. Recent market volatility has heightened fears on Wall Street, with significant drops in major indices. 
  2.  Dividend stocks like Pfizer and Starbucks are highlighted as potentially resilient choices in turbulent times. 
  3. Both companies have faced recent challenges but offer attractive yields and potential for capital appreciation. 

2 Reliable Dividend Stocks for August Amid Market Volatility 

After a robust first half where the S&P 500 Index ($SPX) and the Nasdaq Composite Index ($NASX) saw double-digit returns with minimal volatility, fears have returned to Wall Street. The Cboe Volatility Index ($VIX), often referred to as the market's fear gauge, spiked to its highest level since March 2020. 

On Monday, the S&P 500 experienced its worst day since 2022, and the Nasdaq Composite’s year-to-date gains are now around 9% as the tech rally has stalled. This volatility is likely to concern more cautious market participants.  

Dividend stocks can help mitigate some of this volatility. Pfizer (NYSE:PFE) and Starbucks (NASDAQ:SBUX) are two dividend-paying stocks that could be worth considering this August. Both have underperformed in recent years, but their substantial dividend yields provide a buffer, along with potential for capital appreciation. 

Pfizer: A Stable Pharmaceutical Giant 

Pfizer offers a dividend yield of over 5.5%, making it a solid defensive option in volatile markets. Currently, Pfizer is transitioning from its COVID-19 related revenue streams, with new drug developments and strategic acquisitions like Seagen contributing to its growth. 

Pfizer's second-quarter earnings exceeded expectations, leading the company to raise its 2024 revenue guidance by $1 billion, now projected between $59.5 billion and $62.5 billion. The adjusted earnings per share (EPS) guidance was also increased by 30 cents, now ranging from $2.45 to $2.65. Despite some challenges, Pfizer's stock trades at a relatively low price-to-earnings (PE) ratio of just over 11x, making it an attractive option for dividend-seekers. 

Starbucks: A Steady Performer 

Starbucks, though not immune to economic downturns, offers a dividend yield of 3.1%, more than twice that of the S&P 500 Index. Despite facing various headwinds, including market saturation in North America and challenges in China, the coffee giant continues to focus on its dividend, maintaining a payout ratio of 50%. 

Activist investor Elliott Management has recently taken a stake in Starbucks, engaging constructively with its management. This, coupled with the company's ongoing efforts to navigate market challenges, positions Starbucks as a potential candidate for both stable dividends and capital growth. 

Both Pfizer and Starbucks present interesting cases for those looking to navigate the current market volatility with the stability of dividend stocks. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.